Autres langues Harvard Bioscience, Inc.

Actions

HBIO

US4169062043

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 17:34:03 20/08/2026			Varia. 5j.	Varia. 1 janv.
7,510 ^USD	+6,07%		+13,79%	+13,49%

11/08	Harvard Bioscience, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
11/08	Transcript : Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026

Autres langues

11/08	Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
11/08	Harvard Bioscience: Q2 Earnings Snapshot
11/08	Harvard Bioscience Announces Second Quarter 2026 Financial Results
11/08	Harvard Bioscience, Inc. Raises Earnings Guidance for the Full-Year 2026
11/08	Harvard Bioscience, Inc. Provides Earnings Guidance for the Third Quarter of 2026
28/07	Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
12/05	Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
12/05	Harvard Bioscience : Q1 2026 Harvard Bioscience, Inc. Earnings Conference Call
12/05	Harvard Bioscience: Q1 Earnings Snapshot
12/05	Harvard Bioscience Announces First Quarter 2026 Financial Results
12/05	Harvard Bioscience, Inc. Provides Earnings Guidance for the Second Quarter 2026 and Reaffirms Earnings Guidance for the Full Year 2026
07/05	Harvard Bioscience to Participate in Upcoming Investor Conferences
28/04	Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
12/03	Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
12/03	Harvard Bioscience, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026
12/03	Harvard Bioscience: Q4 Earnings Snapshot
12/03	Harvard Bioscience : Q4 2025 Harvard Bioscience, Inc. Earnings Conference Call
12/03	Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
10/03	Harvard Bioscience, Inc. Appoints Mark Frost as Treasurer, Effective March 6, 2026
10/03	Harvard Bioscience, Inc. Appoints Mark Frost as Chief Financial Officer, Effective March 6, 2026
06/03	Harvard Bioscience Declares Reverse Stock Split
06/03	Harvard Bioscience announces reverse stock split
06/03	Harvard Bioscience Announces Reverse Stock Split
03/03	Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
26/02	Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET